Scroll to top

Where
Science
Meets
Business

Open doors for your life sciences company—and catalyze your growth—through our biotech investor relations firm.

Reach out

Our Model:

An array of plug-and-play services.

More information

With a seamless and multifaceted strategy, we become an integral part of your team. Whether you’re a new or established business, our background in biotech, our brand-building expertise, and our relationships on Wall Street can develop fresh investors and interest in your idea.

IPO Advisory & S-1 Preparation

We can prepare your S-1, introduce you to bankers, create your roadshow deck, advise you on an IPO syndicate, and ensure the entire process runs smoothly.

Investor Relations

Core investor relations firm functions, including creative services, corporate presentations, and a trusted company liaison for Wall Street.

Corporate Communications

Comprehensive in-house support, from overall company messaging to press release strategy, development, and distribution.

Media Relations

Tailored to your sector and region, we can develop a thoughtful media strategy to build visibility and understanding of your science.

About Us

Tap into
our biotech
business background.

Our offerings

Our Clients

Working with
top life sciences
companies.

Who we work with
20+

Public & Private Biotechs

$1.4B

In Institutional Investments

8

Nasdaq IPOs

Testimonials

Hear from
our clients.

Heron Therapeutics, Inc. (HRTX)
“As a commercial stage company with multiple franchises, Heron has a big responsibility to communicate effectively to our audiences. Amy and the team at Juniper Point have been great for us – they are laser focused on execution and have been key to our successful interactions with the Street over the last several years. I am proud to endorse the firm.”
David L. Szekeres

Chief Operating Officer

Forge Therapeutics
“Our goal is to be a leading biotech company in San Diego and by default a significant company in California and possibly nationwide. Juniper Point is helping us achieve this strategic vision.”
Zachary Zimmerman, PhD

CEO

Evotec AG
“With activities spanning various disease areas, diverse technology platforms and a unique business model, Evotec can be a challenge to communicate. The team at Juniper Point have deep insight into the Pharma and biotech industries and understand our audience’s needs extremely well. Their research and support have helped us significantly increase our visibility with both investors and potential partners in the US.”
Gabriele Hansen

VP

Prometheus Biosciences
“Amy is a trusted, strategic partner to me and the entire team at Prometheus Biosciences. She filled an internal gap leading IR and communications, helping us raise awareness of the company on Wall Street, close on a cross-over and eventually go public on Nasdaq. I am proud to endorse Juniper Point.”
Mark McKenna

CEO

Let’s Collaborate

Need a trusted partner?
Let’s talk.

Reach out

From positioning your biotech company in the market to providing creative services, our seasoned team helps your idea stand out—and succeed.